Growth factor modulation
The biggest application segment of GLP-1 receptor agonists is the management of Type 2 diabetes, which will comprise 61.8% market share in 2025, as a direct result of their initial indication and approval for glycemic control
And I cant do that if Im dead. Layla, who explained that she suffered from her eating disorder prior to getting on GLP-1, noted that she used the weight loss medication as a crutch. Obviously not eating all day, youre going to get hunger cues, and thats the hard part about having an eating disorder, is that you still have those, she said
You can read product labels to confirm the product has been authorized for sale by Health Canada
What This Means for Your Business
Vascular and systemic inflammation accelerate small-vessel disease, blood-brain barrier injury, and neuroinflammation all implicated in cognitive decline